| 參考文獻 |
1
|
Adams HP Jr, Brott TG, Crowell RM, Furlana J, Gomez CR, Grotta J, Helgason, Marler JR, Woolson RF, Zivin JA, Feinberg W, Mayberg M. Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994;25:1901-1904.
|
2
|
Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF. Guidelines for the early management of adults with ischemic stroke. Stroke 2007;38:1655-1711.
|
3
|
Barer D. The natural history and functional consequences of dysphagia after hemisphere stroke. J Neurol Neurosurg Psychiatry 1989;52:236-241.
|
4
|
Donnan GA. Investigation of patients with stroke and transient ischaemic attacks. Lancet 1992;339:473-477.
|
5
|
Kidwell CS, Starkman S, Eckstein M, Weems K, Saver JL. Identifying stroke in the field: prospective validation of the Los Angeles Prehospital Stroke Screen (LAPSS). Stroke 2000;31:71-76.
|
6
|
Mathew P, Teasdaele G, Oluoch-Olunmya D. Neurosurgical management of cerebellar hematoma and infarct. Journal of neurology, neurosurgery, and psychiatry 1995; 59:287-292.
|
7
|
Menon B, Shorvon SD. Ischemic stroke in adults and epilepsy. Epilepsy Research. Epub 2009 Sep 8.
|
8
|
Yamaguchi T, Mori E, Minematsu K, Nakagawara J, Hashi K, Saito I, Shinohara Y; Japan Alteplase Clinical Trial (J-ACT) Group. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). Stroke 2006;37:1810-1815.
|
9
|
台灣腦中風學會.台灣腦中風防治指引, 2008.
|